Celcuity (CELC) Receivables - Other (2019 - 2022)

Celcuity (CELC) posted Receivables - Other of $95300.0 for Q2 2022, down 50.63% on a QoQ basis from $193034.0 in Q1 2022, and down 49.84% year-over-year from $190000.0 in Q2 2021.

Celcuity (CELC) Receivables - Other (2019 - 2022) Analysis & Trends

Celcuity's Receivables - Other history runs 4 years deep, the most recent figure standing at $95300.0 for Q2 2022.

  • Quarterly Receivables - Other fell 49.84% year-over-year to $95300.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $95300.0 (down 49.84% YoY) and the FY2021 annual result came in at $298764.0, up 57.24% from the prior year.
  • Receivables - Other was $95300.0 for Q2 2022 at Celcuity, down from $193034.0 in the prior quarter.
  • Across five years, Receivables - Other topped out at $356309.0 in Q3 2021 and bottomed at $95300.0 in Q2 2022.
  • A 4-year average of $206673.4 and a median of $190000.0 in 2019 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2021 — Receivables - Other jumped 87.53% — and 2022, when it slumped 49.84%.
  • Celcuity's Receivables - Other stood at $190000.0 in 2019, then changed by 0.0% to $190000.0 in 2020, then jumped by 57.24% to $298764.0 in 2021, then sank by 68.1% to $95300.0 in 2022.
  • Business Quant data shows CELC's Receivables - Other at $95300.0 in Q2 2022, $193034.0 in Q1 2022, and $298764.0 in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Celcuity 4.13 Bn 4.13 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2022 95,300.00
Jun 30, 2022 95,300.00
Mar 31, 2022 193,034.00
Mar 31, 2022 193,034.00
Dec 31, 2021 298,764.00
Dec 31, 2021 298,764.00
Sep 30, 2021 356,309.00
Sep 30, 2021 356,309.00
Jun 30, 2021 190,000.00
Jun 30, 2021 190,000.00
Mar 31, 2021 190,000.00
Mar 31, 2021 190,000.00
Dec 31, 2020 190,000.00
Dec 31, 2020 190,000.00
Sep 30, 2020 190,000.00
Sep 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Mar 31, 2020 190,000.00
Mar 31, 2020 190,000.00